Multiple drug hypersensitivity syndrome

Current Opinion in Allergy and Clinical Immunology

Volumn 13, Issue 4, 2013, Pages 323-329

  Chiriac, Anca Mirela ^a   Demoly, Pascal ^a,b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Multiple drug hypersensitivity syndrome; Neosensitization; Severe cutaneous adverse reaction

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CORTICOSTEROID; DIURETIC AGENT; LOCAL ANESTHETIC AGENT; PROTON PUMP INHIBITOR; VACCINE;

CROSS REACTION; DELAYED HYPERSENSITIVITY; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; EOSINOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; MULTIPLE DRUG HYPERSENSITIVITY SYNDROME; PATCH TEST; PATHOGENESIS; PENICILLIN ALLERGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RASH; REGULATORY T LYMPHOCYTE; REMISSION; REVIEW; RISK FACTOR; SKIN TEST; SYSTEMIC LUPUS ERYTHEMATOSUS;

DRUG HYPERSENSITIVITY SYNDROME; HUMANS;

EID: 84880132702     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283630c36     Document Type: Review

References (27)

1. Gomes E, Cardoso MF, Praca F, et al. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004; 34: 1597-1601.
2. Mittmann N, Knowles SR, Gomez M, et al. Evaluation of the extent of underreporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf 2004; 27: 477-487.
3. Messaad D, Sahla H, Benahmed S, et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-1006.
4. Joint Task Force on Practice Parameters;American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105: 259-273.
5. Atanaskovic-Markovic M, Gaeta F, Gavrovic-Jankulovic M, et al. Diagnosing multiple drug hypersensitivity in children. Pediatr Allergy Immunol 2012; 23: 785-791.
6. Chiriac AM, Bousquet PJ, Demoly P. Case-control study of a series of multiple drug hypersensitivity patients. Drug Hypersensitivity Meeting 5 Programme 2012; 61-62; http://www.eaaci-dhm2012.com/.
7. Sullivan T, Remedios C, Ong M, et al. Studies of the multiple drug allergy syndrome. J Allergy Clin Immunol 1989; 83:270.
8. Pichler WJ, Daubner B, Kawabata T. Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity. J Dermatol 2011; 38:216-221.
9. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-824.
10. Schiavino D, Nucera E, Roncallo C, et al. Multiple-drug intolerance syndrome: clinical findings and usefulness of challenge tests. Ann Allergy Asthma Immunol 2007; 99: 136-142.
11. Macy E, Ho NJ. Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management. Ann Allergy Asthma Immunol 2012; 108: 88-93.
12. Khoury L, Warrington R. The multiple drug allergy syndrome: a matchedcontrol retrospective study in patients allergic to penicillin. J Allergy Clin Immunol 1996; 98: 462-464.
13. Kamada MM, Twarog F, Leung DY. Multiple antibiotic sensitivity in a pediatric population. Allergy Proc 1991; 12: 347-350.
14. Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-1674.
15. Petri M, Allbritton J. Antibiotic allergy in systemic lupus erythematosus: a casecontrol study. J Rheumatol 1992; 19: 265-269.
16. Neukomm CB, Yawalkar N, Helbling A, et al. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Investig Allergol Clin Immunol 2001; 11: 275-284.
17. Hari Y, Frutig-Schnyder K, Hurni M, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31: 1398-1408.
18. Gex-Collet C, Helbling A, Pichler WJ. Multiple drug hypersensitivity- proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. J Investig Allergol Clin Immunol 2005; 15: 293-296.
19. Gaig P, Garcia-Ortega P, Baltasar M, et al. Drug neosensitization during anticonvulsant hypersensitivity syndrome. J Investig Allergol Clin Immunol 2006; 16: 321-326.
20. Studer M, Waton J, Bursztejn AC, et al. Does hypersensitivity to multiple drugs really exist? Ann Dermatol Venereol 2012; 139: 375-380.
21. Kanny G, Pichler W, Morisset M, et al. T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol 2005; 115: 179-185.
22. Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013; 168: 555-562.
23. Smith JW, Johnson JE, Cluff LE. Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. N Engl J Med 1966; 274:998-1002.
24. Daubner B, Groux-Keller M, Hausmann OV, et al. Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells. Allergy 2012; 67: 58-66.
25. Takahashi R, Kano Y, Yamazaki Y, et al. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009; 182:8071-8079.
26. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64: 183-193.
27. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.